Original paper

Why we should have more collaboration on HTA in Europe: the example of sofosbuvir

Volume: 8, Issue: S1
Published: Oct 5, 2015
Abstract
Results The results of the questionnaire showed that, 7 months after sofosbuvir received market authorisation, in 11 countries the assessment of the effectiveness sofosbuvir had not yet started, in nine it was ongoing and in seven it was completed. Of the 11 countries that had not started an assessment, five Eastern European countries reported that the MAH had not yet submitted an application for reimbursement of sofosbuvir. The analysis also...
Paper Details
Title
Why we should have more collaboration on HTA in Europe: the example of sofosbuvir
Published Date
Oct 5, 2015
Volume
8
Issue
S1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.